Zevin Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Zevin Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,200	Closed	-$204K	–	133
2017 Q3	$204K	Buy	+3,200	New	+$187K	0.05%	124
2016 Q3	–	Sell	-3,256	Closed	-$239K	–	114
2016 Q2	$239K	Hold	3,256	–	–	0.07%	107
2016 Q1	$208K	Buy	3,256 +56	+2%	+$3.53K	0.06%	114
2015 Q4	$220K	Buy	+3,200	New	+$211K	0.06%	117
2015 Q3	–	Sell	-3,200	Closed	-$213K	–	135
2015 Q2	$213K	Hold	3,200	–	–	0.06%	131
2015 Q1	$206K	Buy	+3,200	New	+$200K	0.06%	133

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Zevin Asset Management's BMY Position: Q4 2017 in Review

Zevin Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2017, closing a stake of 3,200 shares — an estimated $204K sold.

Zevin Asset Management first reported a position in BMY in Q1 2015 and held it in 6 quarters. The position peaked at $239K in Q2 2016. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

Zevin Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2017 after selling out during the quarter.
Zevin Asset Management sold 3,200 Bristol-Myers Squibb shares in Q4 2017, an estimated $204K.
Zevin Asset Management first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 6 quarters.
Zevin Asset Management's Bristol-Myers Squibb position peaked at $239K in Q2 2016.
1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Zevin Asset Management's 13F filing for Q4 2017, filed 5 Feb 2018.